RecruitingPhase 3NCT06654882

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Duke University
Intervention
TNFi (Tumor Necrosis Factor inhibitor) medication(drug)
Enrollment
400 enrolled
Eligibility
2-17 years · All sexes
Timeline
20262026

Study locations (5)

Collaborators

Patient-Centered Outcomes Research Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06654882 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis

← Back to all trials